Brazil St Paul pharmaceutical materials exhibition Fi Brasil

Sponsored by UBM, it is a new market for pharmaceutical raw materials in the world after CPhI Worldwide, CPhI China, CPhI Japan and CPhI India.

With the appeal of CPhI, the exhibition was held in Brazil for the second time in 2009 and achieved good results. The booth was sold out six months ahead of schedule.

In 2013, CPhI South America replaced its venue to the pavilion in downtown Sao Paulo, where it was co-hosted with Fi South America, killing two birds with one stone for exhibitors and spectators across two industries.

The 2013 exhibition attracted a large number of leading pharmaceutical and food enterprises from Brazil or other countries, such as BASF, DSM, HETERO, ANASTACIO, DOHLER.

Market Background: Latin America is the fourth largest pharmaceutical and chemical market in the world and is attracting investment from enterprises from all over the world.

Thanks to the revision of relevant laws, the pharmaceutical market in Latin America and Central America is developing rapidly.

According to statistics, the sales of Latin America and China and the United States have reached 3.3 billion US dollars, growing at a rate of 13% annually, twice the world average growth rate, and the market prospects are very promising.

The vigorous pharmaceutical market in South America has also led to a steady increase in overseas production and investment by pharmaceutical manufacturers in the region.

Scope of exhibits:

Pharmaceutical raw materials, intermediates, excipients, natural extracts, fine chemicals, contract research, customized production, market services, etc.